• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT1调节p53突变的人角质形成细胞中的微小RNA加工缺陷。

SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.

作者信息

Herbert Katharine J, Cook Anthony L, Snow Elizabeth T

机构信息

School of Health Sciences, University of Tasmania, Launceston, TAS 7250, Australia.

School of Health Sciences, University of Tasmania, Launceston, TAS 7250, Australia.

出版信息

J Dermatol Sci. 2014 May;74(2):142-9. doi: 10.1016/j.jdermsci.2014.01.008. Epub 2014 Jan 31.

DOI:10.1016/j.jdermsci.2014.01.008
PMID:24548601
Abstract

BACKGROUND

Together with p53, the NAD-dependent lysine deacetylase SIRT1 and the microRNA miR-34a form a feedback loop which self-regulates SIRT1 expression and modulates p53-dependent responses. In addition to its well-described role in mediating transcriptional responses to genotoxic stress, p53 may also regulate microRNA processing and maturation.

OBJECTIVE

This study explored the functional relationship among p53, SIRT1 and miR-34a, and the influence of p53 and SIRT1 on microRNA biogenesis and maturation in primary (NHEK) and p53-mutated (HaCaT) keratinocyte cell lines.

METHODS

RNAi, miRNA target site blocking oligonucleotides and small molecule inhibitors were used to modulate activity and expression of SIRT1 and p53. Changes in microRNA and mRNA were analysed by qRT-PCR and protein expression was determined by immunoblotting.

RESULTS

Mature miR-34a decreased in p53-suppressed NHEK cells, whereas ablation of SIRT1 reduced the primary transcript (pri-miR-34a). When either SIRT1 expression or activity was inhibited in combination with p53 ablation, pri-miR-34a levels increased and mature miR-34a levels decreased. Under these same conditions, additional p53-regulated microRNAs (miRs 16-1/15, 145 and 107) also failed to mature. In HaCaT cells, primary microRNA transcripts for miR-16-1/15, miR-145 miR200c/141 and miRNA-107, but not miR-34a, were approximately 8-fold higher than in NHEK cells. However, the levels of mature microRNA sequences in HaCaT cells were only 1.5-2 fold higher (miR-16-1, miR-145), unchanged (miR-107) or decreased (miR-200c/141, miR-34a) compared to NHEK cells.

CONCLUSIONS

Our results suggest that p53 mutations interfere with efficient microRNA biogenesis in keratinocytes, and that SIRT1 functions in combination with p53 in this process.

摘要

背景

烟酰胺腺嘌呤二核苷酸(NAD)依赖性赖氨酸脱乙酰酶SIRT1与p53以及微小RNA miR-34a共同形成一个反馈环,该反馈环可自我调节SIRT1的表达并调节p53依赖性反应。除了在介导对基因毒性应激的转录反应中所描述的作用外,p53还可能调节微小RNA的加工和成熟。

目的

本研究探讨了p53、SIRT1和miR-34a之间的功能关系,以及p53和SIRT1对原代角质形成细胞(NHEK)和p53突变的角质形成细胞(HaCaT)系中微小RNA生物合成和成熟的影响。

方法

使用RNA干扰、微小RNA靶位点阻断寡核苷酸和小分子抑制剂来调节SIRT1和p53的活性和表达。通过定量逆转录聚合酶链反应(qRT-PCR)分析微小RNA和信使核糖核酸(mRNA)的变化,并通过免疫印迹法测定蛋白质表达。

结果

在p53受抑制的NHEK细胞中,成熟的miR-34a减少,而SIRT1的缺失则降低了初级转录本(pri-miR-34a)。当SIRT1的表达或活性与p53缺失联合受到抑制时,pri-miR-34a水平升高,而成熟的miR-34a水平降低。在相同条件下,其他p53调节的微小RNA(miRs 16-1/15、145和107)也未能成熟。在HaCaT细胞中,miR-16-1/15、miR-145、miR200c/141和miRNA-107的初级微小RNA转录本,但不包括miR-34a,比NHEK细胞中的大约高8倍。然而,与NHEK细胞相比,HaCaT细胞中成熟微小RNA序列的水平仅高1.5 - 2倍(miR-16-1、miR- miR-145)、不变(miR-107)或降低(miR-200c/141、miR-34a)。

结论

我们的结果表明,p53突变会干扰角质形成细胞中高效的微小RNA生物合成,并且SIRT1在此过程中与p53共同发挥作用。

相似文献

1
SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.SIRT1调节p53突变的人角质形成细胞中的微小RNA加工缺陷。
J Dermatol Sci. 2014 May;74(2):142-9. doi: 10.1016/j.jdermsci.2014.01.008. Epub 2014 Jan 31.
2
SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.SIRT1 抑制可恢复 p53 突变的人角质形成细胞的凋亡敏感性。
Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288-97. doi: 10.1016/j.taap.2014.04.001. Epub 2014 Apr 12.
3
MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.微小 RNA-34a 调节冠心病相关长寿蛋白 SIRT1:他汀类药物对 SIRT1 和微小 RNA-34a 表达的影响。
Clin Sci (Lond). 2012 Aug 1;123(3):161-71. doi: 10.1042/CS20110563.
4
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.微小 RNA-34a:p53 突变型神经胶质瘤细胞系 U251 中的一种新型肿瘤抑制因子。
Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.
5
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.熊去氧胆酸抑制大鼠肝脏中 miR-34a/SIRT1/p53,激活人类非酒精性脂肪性肝病的疾病严重程度。
J Hepatol. 2013 Jan;58(1):119-25. doi: 10.1016/j.jhep.2012.08.008. Epub 2012 Aug 15.
6
Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.二甲双胍诱导微小RNA-34a下调Sirt1/Pgc-1α/Nrf2通路,导致野生型p53癌细胞对氧化应激和治疗药物的敏感性增加。
Free Radic Biol Med. 2014 Sep;74:21-34. doi: 10.1016/j.freeradbiomed.2014.06.010. Epub 2014 Jun 24.
7
Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.一氧化碳通过调节miR-34a/SIRT1通路来预防肝缺血/再灌注损伤。
Biochim Biophys Acta. 2015 Jul;1852(7):1550-9. doi: 10.1016/j.bbadis.2015.04.017. Epub 2015 Apr 23.
8
Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.miR-34a/SIRT1/p53信号通路的激活通过诱导肝细胞而非肝星状细胞凋亡促进肝纤维化进展。
PLoS One. 2016 Jul 7;11(7):e0158657. doi: 10.1371/journal.pone.0158657. eCollection 2016.
9
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.miR-34a对前列腺癌PC3细胞生长和化疗耐药性的影响。
Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1.
10
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.烟酰胺通过激活 p53/miR-34a/SIRT1 肿瘤抑制网络来阻断慢性淋巴细胞白血病细胞的增殖并诱导其凋亡。
Cancer Res. 2011 Jul 1;71(13):4473-83. doi: 10.1158/0008-5472.CAN-10-4452. Epub 2011 May 12.

引用本文的文献

1
MicroRNA-34a: the bad guy in age-related vascular diseases.miRNA-34a:与年龄相关的血管疾病中的“坏家伙”。
Cell Mol Life Sci. 2021 Dec;78(23):7355-7378. doi: 10.1007/s00018-021-03979-4. Epub 2021 Oct 26.
2
Alternative mechanisms of miR-34a regulation in cancer.miR-34a 在癌症中的调控的其他机制。
Cell Death Dis. 2017 Oct 12;8(10):e3100. doi: 10.1038/cddis.2017.495.
3
Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.膀胱癌中微小RNA的失调:生物发生过程异常导致表达改变。
Oncotarget. 2017 Apr 18;8(16):27547-27568. doi: 10.18632/oncotarget.15173.
4
MiRNAs in β-Cell Development, Identity, and Disease.β细胞发育、特性及疾病中的微小RNA
Front Genet. 2017 Jan 11;7:226. doi: 10.3389/fgene.2016.00226. eCollection 2016.
5
Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity.癌症中微小RNA生物合成的失调:突变型p53对Drosha复合体活性的影响。
J Exp Clin Cancer Res. 2016 Mar 12;35:45. doi: 10.1186/s13046-016-0319-x.